Inhibition of BMK1 pathway suppresses cancer stem cells through BNIP3 and BNIP3L

Cancer stem cells (CSCs) possess many characteristics associated with stem cells and are believed to drive tumor initiation. Although targeting of CSCs offers great promise for the new generation of therapeutics, lack of the effective drugable target and appropriate pharmacological reagents signific...

Full description

Bibliographic Details
Main Authors: Song, Chengli, Xu, Qiang, Jiang, Kui, Zhou, Guangyu, Yu, Xuebin, Wang, Lina, Zhu, Yuting, Fang, Liping, Yu, Zhe, Lee, Jiing-Dwan, Yu, Shi-Cang, Yang, Qingkai
Format: Online
Language:English
Published: Impact Journals LLC 2015
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741765/